SuppreMol, Baxter deal

Baxter acquired SuppreMol for EUR200 million ($223.9 million). SuppreMol’s lead compound is SM101,

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE